Table 1 Baseline data for all the HIV positive screened with the QFT in tube test.
From: Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test
All 590 | |
|---|---|
Age, median years (25th–75th quartile) | 43 (37–50) |
Male sex, no (%) | 434 (74) |
Ethnicity, no (%) | |
Danish | 440 (74) |
Non-Danish European | 26 (4) |
North American | 4 (1) |
African | 78 (13) |
Asian | 26 (5) |
Middle Eastern | 10 (2) |
Latin American | 7 (1) |
Tuberculosis no. (%) | |
Previous TB diagnosis | 31 (5) |
Tuberculosis risk factors, no (%) | |
History of exposure, | 60 (10) |
Long term residence in a TB endemic country a | 122 (21) |
IVDU | 69 (12) |
≥1 risk factor | 218(37) |
HIV status | |
Age at HIV diagnosis, median years (25th–75th quartile) | 34 (28–41) |
Years with HIV diagnosis, median years (25th–75th quartile) | 8.5 (4–14) |
AIDS diagnosed, no (%) | 118 (20) |
HAART treatment, no (%) | 448 (76) |
CD4 cell count | |
CD4 cell count, mean (± s.d.) | 523 (± 278) |
0–99 CD4 cells/μL, (%) | 17 (3) |
100–199 CD4 cells/μL, (%) | 37 (6) |
200–300 CD4 cells/μL, (%) | 63 (11) |
>300 CD4 cells/μL | 473 (80) |
HIV RNA, no (%) | |
<500 copies/mL | 439 (74) |
500 – 50,000 copies/mL | 95 (16) |
>50,000 copies/mL | 56 (9) |
Factors presumed to influence immune status | |
Diabetes, no. (%) | 20 (3) |
Alc. Abuse, no (%) | 63 (11) |